- Home
- KRUS vs COLL Comparison
KRUS vs COLL Comparison
Compare KRUS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- COLL
- Stock Information
- Founded
- KRUS 2008
- COLL 2002
- Country
- KRUS United States
- COLL United States
- Employees
- KRUS N/A
- COLL N/A
- Industry
- KRUS Restaurants
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- KRUS Consumer Discretionary
- COLL Health Care
- Exchange
- KRUS Nasdaq
- COLL Nasdaq
- Market Cap
- KRUS 1.0B
- COLL 1.0B
- IPO Year
- KRUS 2019
- COLL 2015
- Fundamental
- Price
- KRUS $69.85
- COLL $29.13
- Analyst Decision
- KRUS Buy
- COLL Strong Buy
- Analyst Count
- KRUS 8
- COLL 5
- Target Price
- KRUS $89.75
- COLL $43.60
- AVG Volume (30 Days)
- KRUS 190.7K
- COLL 304.0K
- Earning Date
- KRUS 04-03-2025
- COLL 02-27-2025
- Dividend Yield
- KRUS N/A
- COLL N/A
- EPS Growth
- KRUS N/A
- COLL 757.11
- EPS
- KRUS N/A
- COLL 2.16
- Revenue
- KRUS $250,841,000.00
- COLL $599,245,000.00
- Revenue This Year
- KRUS $20.81
- COLL $13.25
- Revenue Next Year
- KRUS $20.29
- COLL $17.67
- P/E Ratio
- KRUS N/A
- COLL $13.47
- Revenue Growth
- KRUS 25.68
- COLL 9.62
- 52 Week Low
- KRUS $48.66
- COLL $28.39
- 52 Week High
- KRUS $122.81
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- KRUS 38.13
- COLL 37.61
- Support Level
- KRUS $74.05
- COLL $29.39
- Resistance Level
- KRUS $83.80
- COLL $30.39
- Average True Range (ATR)
- KRUS 4.80
- COLL 1.00
- MACD
- KRUS 0.30
- COLL -0.24
- Stochastic Oscillator
- KRUS 7.59
- COLL 11.04
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.